|
RBM39 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.304000E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.055700E-02 |
| Normal-vs-Stage2 |
4.796000E-02 |
| Normal-vs-Stage3 |
3.765200E-01 |
| Normal-vs-Stage4 |
4.464400E-01 |
| Stage1-vs-Stage2 |
5.867800E-01 |
| Stage1-vs-Stage3 |
2.366000E-01 |
| Stage1-vs-Stage4 |
2.531000E-01 |
| Stage2-vs-Stage3 |
1.969560E-01 |
| Stage2-vs-Stage4 |
1.792760E-01 |
| Stage3-vs-Stage4 |
9.377600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.703380E-01 |
| Normal-vs-AfricanAmerican |
2.783000E-04 |
| Normal-vs-Asian |
3.612800E-04 |
| Caucasian-vs-AfricanAmerican |
2.229100E-04 |
| Caucasian-vs-Asian |
1.358190E-02 |
| AfricanAmerican-vs-Asian |
4.205600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.994790E-01 |
| Normal-vs-Female |
2.360500E-03 |
| Male-vs-Female |
2.305600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.478600E-01 |
| Normal-vs-Age(41-60Yrs) |
9.461700E-03 |
| Normal-vs-Age(61-80Yrs) |
1.313150E-01 |
| Normal-vs-Age(81-100Yrs) |
5.202800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.273230E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.663600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.008800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.283600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.803400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.742800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.64106999999136E-05 |
| Normal-vs-Grade 2 |
2.177300E-03 |
| Normal-vs-Grade 3 |
3.244000E-01 |
| Normal-vs-Grade 4 |
5.536200E-01 |
| Grade 1-vs-Grade 2 |
3.215900E-02 |
| Grade 1-vs-Grade 3 |
8.388500E-04 |
| Grade 1-vs-Grade 4 |
1.026280E-04 |
| Grade 2-vs-Grade 3 |
1.498030E-02 |
| Grade 2-vs-Grade 4 |
2.498700E-03 |
| Grade 3-vs-Grade 4 |
1.421160E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.457680E-03 |
| Normal-vs-ccB subtype |
7.067400E-01 |
| ccA subtype-vs-ccB subtype |
1.186010E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.314500E-02 |
| Normal-vs-N1 |
3.287200E-01 |
| N0-vs-N1 |
1.410400E-01 |
|
|
